Skip to content
Disclosery

EXANE DERIVATIVES: SMG position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on SMG, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 5,400 SMG shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 5,400 shares
    Change vs previous 13F -1,376 shares

    0.25% of the 13F portfolio, value $426,459.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 6,776 shares
    Change vs previous 13F -23 shares

    0.23% of the 13F portfolio, value $833,126.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 6,799 shares
    Change vs previous 13F +6,799 shares

    0.27% of the 13F portfolio, value $1,094,599.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-06-30
    13F 0 shares
    Change vs previous 13F -204 shares

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  5. period ended2021-03-31
    13F 204 shares
    Change vs previous 13F not available

    0.02% of the 13F portfolio, value $49,972.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).